Anymedi Statistics

Total Valuation

Anymedi has a market cap or net worth of KRW 14.44 billion.

Market Cap	14.44B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Anymedi has 8.98 million shares outstanding.

Current Share Class	8.98M
Shares Outstanding	8.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	48.49%
Owned by Institutions (%)	1.72%
Float	1.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	43.20
PB Ratio	2.16
P/TBV Ratio	2.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.55.

Current Ratio	2.05
Quick Ratio	1.90
Debt / Equity	0.55
Debt / EBITDA	n/a
Debt / FCF	-0.48
Interest Coverage	-21.88

Financial Efficiency

Return on equity (ROE) is -248.61% and return on invested capital (ROIC) is -54.20%.

Return on Equity (ROE)	-248.61%
Return on Assets (ROA)	-36.89%
Return on Invested Capital (ROIC)	-54.20%
Return on Capital Employed (ROCE)	-80.32%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.03
Inventory Turnover	7.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.05% in the last 52 weeks. The beta is 0.90, so Anymedi's price volatility has been similar to the market average.

Beta (5Y)	0.90
52-Week Price Change	-17.05%
50-Day Moving Average	1,399.16
200-Day Moving Average	1,633.29
Relative Strength Index (RSI)	59.03
Average Volume (20 Days)	265

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Anymedi had revenue of KRW 334.34 million and -11.16 billion in losses. Loss per share was -1,998.00.

Revenue	334.34M
Gross Profit	-315.71M
Operating Income	-7.87B
Pretax Income	-11.16B
Net Income	-11.16B
EBITDA	-6.89B
EBIT	-7.87B
Loss Per Share	-1,998.00

Full Income Statement

Balance Sheet

The company has 3.14 billion in cash and 3.65 billion in debt, giving a net cash position of -508.11 million or -56.61 per share.

Cash & Cash Equivalents	3.14B
Total Debt	3.65B
Net Cash	-508.11M
Net Cash Per Share	-56.61
Equity (Book Value)	6.68B
Book Value Per Share	1,078.33
Working Capital	2.03B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.34 billion and capital expenditures -1.20 billion, giving a free cash flow of -7.54 billion.

Operating Cash Flow	-6.34B
Capital Expenditures	-1.20B
Free Cash Flow	-7.54B
FCF Per Share	-840.41

Full Cash Flow Statement

Margins

Gross Margin	-94.43%
Operating Margin	-2,354.10%
Pretax Margin	-3,337.30%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Anymedi does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-77.26%
FCF Yield	-52.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Anymedi has an Altman Z-Score of -4.47 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.47
Piotroski F-Score	1